These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28631963)

  • 1. Tumor-penetrating Peptide-integrated Thermally Sensitive Liposomal Doxorubicin Enhances Efficacy of Radiofrequency Ablation in Liver Tumors.
    Yan F; Wang S; Yang W; Goldberg SN; Wu H; Duan WL; Deng ZT; Han HB; Zheng HR
    Radiology; 2017 Nov; 285(2):462-471. PubMed ID: 28631963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Thermosensitive Liposomal Vinorelbine Improve End-Point Survival after Percutaneous Radiofrequency Ablation of Liver Tumors in a Mouse Model?
    Wang S; Mei XG; Goldberg SN; Ahmed M; Lee JC; Gong W; Han HB; Yan K; Yang W
    Radiology; 2016 Jun; 279(3):762-72. PubMed ID: 26785043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals.
    Ahmed M; Liu Z; Lukyanov AN; Signoretti S; Horkan C; Monsky WL; Torchilin VP; Goldberg SN
    Radiology; 2005 May; 235(2):469-77. PubMed ID: 15858089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model?
    Yang W; Ahmed M; Elian M; Hady el-SA; Levchenko TS; Sawant RR; Signoretti S; Collins M; Torchilin VP; Goldberg SN
    Radiology; 2010 Dec; 257(3):685-96. PubMed ID: 20858851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
    Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
    J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes.
    Andriyanov AV; Koren E; Barenholz Y; Goldberg SN
    PLoS One; 2014; 9(5):e92555. PubMed ID: 24786533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
    Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
    J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.
    Yu KF; Zhang WQ; Luo LM; Song P; Li D; Du R; Ren W; Huang D; Lu WL; Zhang X; Zhang Q
    Int J Nanomedicine; 2013; 8():2473-85. PubMed ID: 23885174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, Tissue Distribution and Therapeutic Effect of Cationic Thermosensitive Liposomal Doxorubicin Upon Mild Hyperthermia.
    Dicheva BM; Seynhaeve AL; Soulie T; Eggermont AM; Ten Hagen TL; Koning GA
    Pharm Res; 2016 Mar; 33(3):627-38. PubMed ID: 26518763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.
    Wang K; Zhang X; Liu Y; Liu C; Jiang B; Jiang Y
    Biomaterials; 2014 Oct; 35(30):8735-47. PubMed ID: 25023394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation.
    Ahmed M; Monsky WE; Girnun G; Lukyanov A; D'Ippolito G; Kruskal JB; Stuart KE; Torchilin VP; Goldberg SN
    Cancer Res; 2003 Oct; 63(19):6327-33. PubMed ID: 14559820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal combination therapies for local drug delivery by magnetic resonance-guided high-intensity focused ultrasound.
    Hijnen N; Kneepkens E; de Smet M; Langereis S; Heijman E; Grüll H
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):E4802-E4811. PubMed ID: 28566498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model.
    Goldberg SN; Girnan GD; Lukyanov AN; Ahmed M; Monsky WL; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Torchillin VP; Halpern EF; Kruskal JB
    Radiology; 2002 Mar; 222(3):797-804. PubMed ID: 11867804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant liposomal doxorubicin markedly affects radiofrequency ablation-induced effects on periablational microvasculature.
    Moussa M; Goldberg SN; Tasawwar B; Sawant RR; Levchenko T; Kumar G; Torchilin VP; Ahmed M
    J Vasc Interv Radiol; 2013 Jul; 24(7):1021-33. PubMed ID: 23664809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
    Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
    J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
    Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
    J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous tumor ablation: reduced tumor growth with combined radio-frequency ablation and liposomal doxorubicin in a rat breast tumor model.
    D'Ippolito G; Ahmed M; Girnun GD; Stuart KE; Kruskal JB; Halpern EF; Goldberg SN
    Radiology; 2003 Jul; 228(1):112-8. PubMed ID: 12808127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model.
    Monsky WL; Kruskal JB; Lukyanov AN; Girnun GD; Ahmed M; Gazelle GS; Huertas JC; Stuart KE; Torchilin VP; Goldberg SN
    Radiology; 2002 Sep; 224(3):823-9. PubMed ID: 12202721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.